PCDH20 REVERSES CHEMOTHERAPY RESISTANCE IN HEPATOCELLUAR CARCINOMA BY DOWN-REGULATING MDR1 AND NANOG EXPRESSION VIA INHIBITING THE PHOSPHORYLATION OF SMAD3

被引：0
|
作者：
Wu, Yan Q.
Zhang, Shenghong
机构：
来源：
GASTROENTEROLOGY | 2018年 / 154卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1468
引用
收藏
页码：S1123 / S1123
页数：1
相关论文
共 7 条
  • [1] Sorafenib reverses resistance of gastric cancer to treatment by cisplatin through down-regulating MDR1 expression
    Yi-sheng Huang
    Zhi Xue
    Hua Zhang
    Medical Oncology, 2015, 32
  • [2] Sorafenib reverses resistance of gastric cancer to treatment by cisplatin through down-regulating MDR1 expression
    Huang, Yi-sheng
    Xue, Zhi
    Zhang, Hua
    MEDICAL ONCOLOGY, 2015, 32 (02)
  • [3] Chronic smoking increases tumorigenicity and imparts resistance to platinum-based chemotherapy partly by down-regulating Smad3 in non-small cell lung cancer
    Samanta, Debangshu
    Datta, Pran K.
    CANCER RESEARCH, 2012, 72
  • [4] Resveratrol alleviates bleomycin-induced pulmonary fibrosis by inhibiting epithelial-mesenchymal transition and down-regulating TLR4/NF-ΚB and TGF-β1/smad3 signalling pathways in rats
    Wang, Lei
    Shao, Mei
    Jiang, Wei
    Huang, Yangfeng
    TISSUE & CELL, 2022, 79
  • [5] Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway
    Chen, Jie-Ru
    Jia, Xiu-Hong
    Wang, Hong
    Yi, Ying-Jie
    Wang, Jian-Yong
    Li, You-Jie
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 48 (05) : 2063 - 2070
  • [6] MiR-141 Activates Nrf2-Dependent Antioxidant Pathway via Down-Regulating the Expression of Keap1 Conferring the Resistance of Hepatocellular Carcinoma Cells to 5-Fluorouracil
    Shi, Liang
    Wu, Lili
    Chen, Zhanguo
    Yang, Jianrong
    Chen, Xiaofei
    Yu, Fangyou
    Zheng, Fang
    Lin, Xiangyang
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2015, 35 (06) : 2333 - 2348
  • [7] Salidroside protects mice against CCl4-induced acute liver injury via down-regulating CYP2E1 expression and inhibiting NLRP3 inflammasome activation
    Zhang, Xue
    Kuang, Ge
    Wan, Jingyuan
    Jiang, Rong
    Ma, Li
    Gong, Xia
    Liu, Xing
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 85
1